Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

DrugDev Thought Leaders Share Experience and Insights on How Transformative Technology Improves Clinical Trials at Premier Pharma and Biotech Industry Conferences in Q2
  • USA - English


News provided by

DrugDev

Apr 05, 2017, 04:30 ET

Share this article

Share toX

Share this article

Share toX

DrugDev Spark™ - Disrupting Clinical Trials Worldwide
DrugDev Spark™ - Disrupting Clinical Trials Worldwide

Philadelphia PA and London UK (PRWEB) April 05, 2017 -- DrugDev executives will share best practices for transforming clinical trials at pharma and biotech industry events in Q2 2017. These subject matter experts will speak at the following conferences:

DrugDev executives will share best practices for transforming clinical trials at pharma and biotech industry events across the US in Q2 2017.

Post this

ACRP Meeting & Expo 2017, April 28-May 2, Seattle WA
http://conference.acrpnet.org
Signature Series Session – The State of the Industry, April 30, 8:15-9:30am – An expert panel will examine the forces shaping the current and future state of clinical research and explore the individual dynamics of technology, process, and workforce on the industry and their effect on each other. Moderated by Jim Kremidas, ACRP Executive Director, this dynamic session will expand attendees’ thinking of the industry as we prepare for its future state. DrugDev President of Data Solutions Elisa Cascade joins fellow panelists Ken Getz, Director and Associate Professor, CSDD, Tufts University; Terri Hinkley, Workforce Innovation Officer, ACRP; and Leanne Madre, Director of Strategy, Clinical Trials, Transformation Initiative at Duke University Medical Center.

Clinical Leader Forum, May 11, Philadelphia PA
http://www.clinicalleaderforum.com
10:45-11:20 am: “Your Trial is Off the Rails: Here’s How to Put it Back on Track” –
Despite the best laid plans, sometimes a trial veers off course. DrugDev Founder and President, SiteStart Melissa “Liss” Easy moderates this session on how to determine if a study needs to be rescued, what team is responsible for study rescue, when to rescue (and when to bail out), and whom to turn to when all else fails. Liss is joined by Molly Rosano, Vice President of Clinical Operations, NuCana; and Beth Harper, President of Clinical Performance Partners.

MAGI East, May 21-24, Philadelphia PA
http://magiworld.org/events
May 23, 9:30- 10:15am Session B112: Sponsor Payments to Sites: How Long Does It Really Take? – DrugDev Vice President, US Payments Holly Leslie MBA joins Laura Hilty, Vice President, Product Management at Nimblify, a Forte company, to discuss how sponsors, CROs, and sites can accelerate payments to investigator sites. Watch a new educational webinar Holly Leslie led with site expert Ana T. Marquez, Founder of Clinical Partners via the DrugDev Knowledge Center.

Additionally, DrugDev will sponsor, exhibit and participate in these events:

• Clinical Trials Patient Experience Summit, April 6-7, San Francisco CA https://panagorapharma.com/connectedpatients
• Clinical Operations in Oncology Trials West Coast 2017, April 11-12, Burlingame CA http://www.arena-international.com/oncologywestcoast
• CHI’s Clinical Trial Innovation Summit, April 24-26, Boston MA http://www.clinicaltrialsummit.com
• Avoca Quality Consortium Summit USA May 10-11 New York City, NY http://theavocagroup.com/quality-consortium/2017-summit-usa/
• Outsourcing in Clinical Trials East Coast, May 23-24, King of Prussia PA http://www.arena-international.com/octeastcoast
• DIA June 18-22, Chicago IL – DrugDev is a sponsor, exhibitor and speaker http://www.diaglobal.org/Flagship/DIA-2017

To arrange a meeting with a DrugDev expert email us at solutions(at)drugdev(dot)com.

About DrugDev
DrugDev helps the world do more clinical trials through industry-wide collaboration, standardization and a beautiful technology experience. The DrugDev Spark™ unified clinical operations suite is comprised of proven solutions used by 85 sponsors and CROs to transform the quality and efficiency of nearly 2,000 clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why the world’s most innovative pharma and biotech companies and CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.

Brenda Nashawaty, DrugDev, http://www.drugdev.com, +1 617-688-3253, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.